Kiran Sonaje

Kiran Sonaje is an accomplished professional in the field of pharmaceutical sciences, currently serving as General Manager of Research Development at Meril since June 2023. Prior to this role, Kiran held significant positions at Axio Biosolutions Private Limited, including Head of Research and Development and Senior Scientist in Research and Development. Kiran's academic background includes a Ph.D. from National Tsing Hua University and an MS in Pharmaceutics from the National Institute of Pharmaceutical Education and Research. Notable previous experiences include serving as a Senior Post-doctoral Fellow at the University of Geneva and working as a Research Scientist-Consultant at Nanomega Medical Corporation, where Kiran designed feasibility studies for protein drug formulations. Additionally, Kiran's early career included a Junior Research Fellow position focused on nanoparticles for oral drug delivery.